IPHA evaluates hundreds of health tech startups every year in order to find six or eight potential investments to improve personalized health in areas like advanced analytics, innovations in quality of patient care and advances in health information technology. After being selected, IPHA directly engages with the company to accomplish critical development milestones, including startup capital and access to Inova personnel and resources. As these companies pass validation milestones, co-investment opportunities become available to individuals, angel investors, family offices in the IPHA investor network.
The IPHA team sifts through hundreds of applicants to identify and invest in a few high potential healthcare startups who can make a difference and deliver superior risk-adjusted returns for investors. This is achieved by providing more than just monetary investment to our portfolio companies. We apply our experience and knowledge from building successful companies to create accelerator programs customized to each startup and work alongside the founders as a team. Our partnership with Inova gives us the ability to validate a company’s impact, provide them with a first customer and position the company for growth.
Our goal at IPHA is to help innovators build personalized healthcare companies that improve health, save lives and money. Our portfolio is curated to meet this goal. We made our first fund investment in late 2017 with HeMemics and have added additional companies since then with more to be announced throughout this year. To learn more about our portfolio, click the button below.